Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertagen versus Boostrix for pertussis booster immunization in young adults
ACTRN12619000944134Phase 3Completed
- Sponsor
- Kids Research Institute Australia
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of paracetamol + caffeine in pertussis (2 arms), sponsored by Kids Research Institute Australia. Primary endpoint: Composite seroconversion rate for PT-IgG and FHA-IgG. Started Jul 2020; status: completed.
02
Drugs
paracetamol + caffeine
03
Conditions
pertussis
Beyond the preview
Go deeper on ACTRN12619000944134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000944134.